---
company: Atomera Inc
ticker: ATOM
form: 8-K
filed: 2026-05-05
accession: 0001683168-26-003493
source: https://www.sec.gov/Archives/edgar/data/1420520/000168316826003493/
---

# Atomera (ATOM) earnings release, May 5, 2026

Atomera Inc (ATOM) · Form 8-K, Item 2.02 · Filed 2026-05-05 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1420520/000168316826003493/)

Atomera Provides

First Quarter 2026 Results

LOS GATOS, Calif. — May 5, 2026 — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the first quarter ended March 31, 2026.

Recent Company Highlights

Management Commentary

“We made excellent progress during the first quarter toward adoption of MST by GAA manufacturers, engaging with another of the four companies that manufacture those advanced transistors. At the same time, we expanded our offerings in GaN beyond power applications to RF where we believe we will substantially grow our TAM and deliver highly differentiated device performance on larger-diameter wafers,” said Scott Bibaud, President and CEO of Atomera. “We are also very pleased to have closed on a $25 million equity raise which brought our cash, cash equivalents and short-term investments to over

$41 million. With this additional capital we are in a strong position to enable our customers to bring MST-enabled products to market.”

Financial Results

The Company incurred a net loss of ($6.1) million, or ($0.17) per basic and diluted share in the first quarter of 2026, compared to a net loss of ($5.2) million, or ($0.14) per basic and diluted share, for the first quarter of 2025. Adjusted EBITDA (a non-GAAP financial measure) in the first quarter of 2026 was a loss of ($4.9) million compared to an adjusted EBITDA loss of ($4.4) million in the first quarter of 2025.

The Company had $41.1 million in cash, cash equivalents and short-term investments as of Mar. 31, 2026, compared to $19.2 million as of December 31, 2025.

The total number of shares outstanding was 38.7 million as of Mar. 31, 2026.

First Quarter 2026 Results Webinar

Atomera will host a live video webinar today to discuss its financial results and recent progress.

Date: Tuesday, May 5, 2026

Time: 2:00 p.m. PT (5:00 p.m. ET)

Webcast: Accessible at https://ir.atomera.com

Note about Non-GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure.

Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation.

Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

About Atomera Incorporated

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon

Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.

Safe Harbor

This press release contains forward-looking statements concerning Atomera

Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise;

(2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and knowhow and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on

Form 10-K filed with the SEC on February 24, 2026. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

-- Financial Tables Follow – Atomera Incorporated

Condensed Balance Sheets

(in thousands, except per share data)

Atomera Incorporated

Condensed Statements of Operations

(in thousands, except per share data)

Atomera Incorporated

Reconciliation to Non-GAAP EBITDA

(Unaudited)

Investor Contact:

Bishop IR

Mike Bishop

(415) 894-9633 investor@atomera.com

## Financial statements

### Income Statement (Three Months Ended — (in thousands, except per share data))

| | Three Months Ended – March 31, – 2026 – (Unaudited) | Three Months Ended – December 31, – 2025 – (Unaudited) | Three Months Ended – March 31, – 2025 – (Unaudited) |
|---|---:|---:|---:|
| Revenue | 11 | 50 | 4 |
| Cost of revenue | -126 | -131 |  |
| Gross profit (loss) | -115 | -81 | 4 |
| Operating expenses | Research and development | 3,457 | 2,740 | 3,255 |
| Operating expenses | General and administrative | 2,333 | 1,505 | 2,088 |
| Operating expenses | Selling and marketing | 419 | 286 | 124 |
| Operating expenses | Total operating expenses | 6,209 | 4,531 | 5,467 |
| Operating expenses | Loss from operations | -6,324 | -4,612 | -5,463 |
| Other income (expense) | Interest income | 197 | 195 | 270 |
| Other income (expense) | Accretion income | 57 |  | 6 |
| Other income (expense) | Interest Expense | -4 | -9 | -21 |
| Other income (expense) | Other income (expense), net | 1 | 1 | -1 |
| Other income (expense) | Total other income (expense), net | 251 | 187 | 254 |
| Other income (expense) | Net loss | -6,073 | -4,425 | -5,209 |
| Other income (expense) | Net loss per common share, basic and diluted | -0.17 | -0.14 | -0.17 |
| Other income (expense) | Weighted average number of common shares outstanding, basic and diluted | 35,256 | 31,590 | 30,243 |

### Income Statement (Three Months Ended — (Unaudited))

| | Three Months Ended – March 31, – 2026 | Three Months Ended – December 31, – 2025 | Three Months Ended – March 31, – 2025 |
|---|---:|---:|---:|
| Net loss (GAAP) | -6,073 | -4,425 | -5,209 |
| Depreciation and amortization | 9 | 13 | 12 |
| Stock-based compensation | 1,406 | 1,334 | 1,009 |
| Interest income | -197 | -195 | -270 |
| Accretion income | -57 |  | -6 |
| Interest expense | 4 | 9 | 21 |
| Other (income) expense, net | -1 | -1 | 1 |
| Net loss non-GAAP EBITDA | -4,909 | -3,265 | -4,442 |

### Balance Sheet (December 31, — (in thousands, except per share data))

| | March 31, – 2026 – (Unaudited) | December 31, – 2025 |
|---|---:|---:|
| Current assets: | Cash and cash equivalents | 14,160 | 19,210 |
| Current assets: | Short-term investments | 26,930 |  |
| Current assets: | Accounts receivable | 41 |  |
| Current assets: | Interest receivable | 139 | 54 |
| Current assets: | Prepaid expenses and other current assets | 788 | 338 |
| Current assets: | Total current assets | 42,058 | 19,602 |
| Current assets: | Property and equipment, net | 51 | 60 |
| Current assets: | Security deposit | 14 | 14 |
| Current assets: | Operating lease right-of-use asset | 1,176 | 884 |
| Current assets: | Financing lease right-of-use asset | 322 | 533 |
| Current assets: | Total assets | 43,621 | 21,093 |
| Current liabilities: | Accounts payable | 677 | 608 |
| Current liabilities: | Accrued expenses | 213 | 168 |
| Current liabilities: | Accrued payroll related expenses | 782 | 650 |
| Current liabilities: | Current operating lease liability | 301 | 147 |
| Current liabilities: | Current financing lease liability | 106 | 420 |
| Current liabilities: | Deferred Revenue | 96 | 7 |
| Current liabilities: | Total current liabilities | 2,175 | 2,000 |
| Current liabilities: | Long-term operating lease liability | 896 | 712 |
| Current liabilities: | Total liabilities | 3,071 | 2,712 |
| Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of March 31, 2026 and December 31, 2025 | Common stock: $0.001 par value, authorized 47,500 shares; 38,723 shares issued and 38,716 outstanding as of March 31, 2026; and 32,354 shares issued and outstanding as of December 31, 2025 | 39 | 32 |
| Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of March 31, 2026 and December 31, 2025 | Additional paid in capital | 288,301 | 260,043 |
| Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of March 31, 2026 and December 31, 2025 | Other comprehensive income (loss) | -23 |  |
| Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of March 31, 2026 and December 31, 2025 | Accumulated deficit | -247,767 | -241,694 |
| Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of March 31, 2026 and December 31, 2025 | Total stockholders’ equity | 40,550 | 18,381 |
| Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of March 31, 2026 and December 31, 2025 | Total liabilities and stockholders’ equity | 43,621 | 21,093 |
